Castle Biosciences Competitors and Similar CompaniesClear all

Castle Biosciences's competitors and similar companies include Pharma Mar and Biocept.

	Castle Biosciences Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.	Pharma Mar Pharma Mar is a biopharmaceutical company that engages in the discovery and development of marine-derived anticancer drugs.	Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
Founding Date	Founding Date 2008	Founding Date 1986	Founding Date 1993
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech medical diagnostics medtech oncology	Tags Healthcare Manufacturing & Industrial biotech chemicals drug development home care medical diagnostics oncology pharma	Tags Healthcare biotech medical diagnostics oncology
Locations	Locations Friendswood, US HQ Phoenix, US	Locations Colmenar Viejo, ES HQ Madrid, ES	Locations San Diego, US HQ
Employees	Employees 61013% increase	Employees 500	Employees 878% decrease
Valuation ($)	Valuation ($) 936.9 m	Valuation ($) 1.4 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $344.2m (FY, 2025)	Revenue (est.) €221.4m (FY, 2025)	Revenue (est.) $25.9m (FY, 2022)
Cost of goods	Cost of goods $71m (FY, 2025)	Cost of goods €12.3m (FY, 2025)	Cost of goods $28.4m (FY, 2022)
Gross profit	Gross profit $273.2m (FY, 2025)	Gross profit €232m (FY, 2025)	Gross profit ($2.5m) (FY, 2022)
Net income	Net income ($24.2m) (FY, 2025)	Net income €75m (FY, 2025)	Net income ($32.1m) (FY, 2022)
Funding
Total funding raised	Total funding raised $ 46.5m	Total funding raised N/A	Total funding raised $ 15.9m